Fundraising Fox

Fl2021-001

San Francisco, US · Founded 2021 · Delaware corporation · 2 known investors

Founders & leadership

JL
June LeeNamed on SEC filing

Board

JT
James TananbaumBoard director
VB
Vikram BajajBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$240M disclosed across 4 rounds · 2021–2024

$40MraisedJul 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Srinivas AkkarajuDirector
  • John R. SchroerExecutive Officer
  • James TananbaumDirector
  • Derrick RichardsonExecutive Officer
  • Patrick MachadoDirector
  • Sapna SrivastavaDirector
  • Martin BablerExecutive Officer, Director
  • Mark BradleyExecutive Officer
  • Zhengbin YaoDirector
  • Sara KleinExecutive Officer
  • David M. GoldsteinExecutive Officer
  • Jorn DrappaExecutive Officer
  • Alan B. ColowickDirector
  • Roy C. HardimanExecutive Officer
Offering amount
$40M
Amount sold
$40M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$129.5MraisedMar 2024 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard GasterDirector
  • Zhengbin YaoDirector
  • Sapna SrivastavaDirector
  • Martin BablerExecutive Officer, Director
  • Alan ColowickDirector
  • Julian BakerDirector
  • James TananbaumDirector
  • Srinivas AkkarajuDirector
Offering amount
$259M
Amount sold
$129.5M
First sale
Mar 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$60MraisedMar 2021 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • June LeeExecutive Officer, Director
  • James TananbaumDirector
  • Michael RomeDirector
Offering amount
$60M
Amount sold
$60M
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$10.5MraisedFeb 2021 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • James TananbaumDirector
  • June LeeExecutive Officer, Director
  • Vikram BajajDirector
Offering amount
$10.5M
Amount sold
$10.5M
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Fl2021-001's investors?
Fl2021-001's investors include Foresite Capital, Samsara BioCapital.
How much funding has Fl2021-001 raised?
Fl2021-001 has disclosed $240M raised across 4 rounds.
Where is Fl2021-001 headquartered?
Fl2021-001 is headquartered in San Francisco, US.